Aerie Pharmaceuticals Announces U.S. Launch of Rocklatan and Increase in Rhopressa Medicare Part D Coverage to Approximately 75% of Lives
DURHAM, N.C.--(BUSINESS WIRE)--May 1, 2019--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercializat…
